Tarceva and Skin blushing/flushing - a phase IV clinical study of FDA data

Summary:

Skin blushing/flushing is reported as a side effect among people who take Tarceva (erlotinib hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Avastin, and have Lung neoplasm malignant.

The phase IV clinical study analyzes which people have Skin blushing/flushing when taking Tarceva. It is created by eHealthMe based on reports of 30,795 people who have side effects when taking Tarceva from the FDA, and is updated regularly.

What is Tarceva?

Tarceva has active ingredients of erlotinib hydrochloride. It is often used in lung cancer. eHealthMe is studying from 31,036 Tarceva users. Check the latest studies of Tarceva.

What is Skin blushing/flushing?

Skin blushing/flushing (a sudden reddening of the face, neck) is found to be associated with 2,020 drugs and 2,930 conditions by eHealthMe. Check the latest studies of Skin blushing/flushing.

On Jul, 06, 2026

30,795 people reported to have side effects when taking Tarceva.
Among them, 50 people (0.16%) have Skin blushing/flushing.

Could Tarceva cause Skin blushing/flushing?

Among these 50 people:

How long have people been on Tarceva when they have Skin blushing/flushing? *

What is the gender of people who have Skin blushing/flushing when taking Tarceva? *

female: 66 %
male: 34 %

What is the age of people who have Skin blushing/flushing when taking Tarceva? *

What are other drugs people take besides Tarceva? *

What are other side effects people have besides Skin blushing/flushing? *

Rashes (redness): 22 people, 44.00%
Diarrhea: 17 people, 34.00%
Itching: 11 people, 22.00%
Nausea (feeling of having an urge to vomit): 10 people, 20.00%
Dyspnea (difficult or laboured breathing): 10 people, 20.00%
Fatigue (feeling of tiredness): 10 people, 20.00%
Headache (pain in head): 9 people, 18.00%
Fever: 8 people, 16.00%
Chest Pain: 7 people, 14.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 6 people, 12.00%

What are the existing conditions these people have? *

Lung Neoplasm Malignant (cancer tumour of lung): 27 people, 54.00%
Lung Cancer Metastatic (lung cancer spreads to other parts): 4 people, 8.00%
Idiopathic Urticaria (allergic reactions, presence of hives with unknown cause): 3 people, 6.00%
Metastases To Meninges (cancer spreads to meninges): 2 people, 4.00%
High Blood Cholesterol: 2 people, 4.00%
Tumor: 2 people, 4.00%
Urticaria (rash of round, red welts on the skin that itch intensely): 2 people, 4.00%
Benign Bone Neoplasm (benign (non-cancerous) tumours of the bone): 2 people, 4.00%
Pain: 2 people, 4.00%
Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 1 person, 2.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tarceva and have Skin blushing/flushing?

- Check whether Skin blushing/flushing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tarceva:

Tarceva (31,036 reports)

Browse all side effects of Tarceva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin blushing/flushing:

Skin blushing/flushing (2,020 drugs)

Browse all the conditions that are associated with Skin blushing/flushing:

Skin blushing/flushing (2,930 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on erlotinib hydrochloride (the active ingredients of Tarceva) and Tarceva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.